» Articles » PMID: 35910797

Bone Tissue Engineering Supported by Bioprinted Cell Constructs with Endothelial Cell Spheroids

Overview
Journal Theranostics
Date 2022 Aug 1
PMID 35910797
Authors
Affiliations
Soon will be listed here.
Abstract

In bone tissue engineering, efficient formation of vascularized bone tissue is a challenging issue. Here, we introduce a new strategy for effectively using multiple cells laden in a hybrid structure, such as endothelial cell (EC) spheroids and homogeneously distributed human adipose stem cells (hASCs) for bone regeneration. To fabricate the EC spheroids, cell-mixed mineral oil was used, and microscale droplets of the cell mixture were interlayered between the bioprinted hASC-laden struts. cellular responses of spheroid-laden multiple-cell constructs have been evaluated by comparing with the cell constructs bioprinted with the mixture of hASCs and ECs. In addition, mastoid obliterated rat model has been used to observe bone formation of those cell constructs. The spheroid-laden multiple-cell constructs induced outstanding angiogenesis and osteogenic activities compared to a conventionally bioprinted multiple-cell construct. The enhanced biological results were clearly due to the EC spheroids, which triggered highly cooperative crosstalk between ECs and stem cells. The co-culture of the hASC constructs with the EC spheroids exhibited enhanced osteogenic- and angiogenic-related gene expression . In addition, in a rat obliterated mastoid model, considerably greater new bone formation and more competent development of new blood vessels were observed compared to those achieved with the normally bioprinted multiple cell-loaded structure. and results demonstrated that the bioprinted spheroid-laden multiple-cell construct is a potential candidate for use in bone tissue engineering.

Citing Articles

Cu(II)-baicalein enhance paracrine effect and regenerative function of stem cells in patients with diabetes.

Liu K, Li R, Wang S, Fu X, Zhu N, Liang X Bioact Mater. 2024; 36:455-473.

PMID: 39055352 PMC: 11269795. DOI: 10.1016/j.bioactmat.2024.03.013.


Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues.

Hwangbo H, Chae S, Kim W, Jo S, Kim G Theranostics. 2024; 14(1):33-55.

PMID: 38164155 PMC: 10750204. DOI: 10.7150/thno.90093.


Bioprinted vascular tissue: Assessing functions from cellular, tissue to organ levels.

Jiang H, Li X, Chen T, Liu Y, Wang Q, Wang Z Mater Today Bio. 2023; 23:100846.

PMID: 37953757 PMC: 10632537. DOI: 10.1016/j.mtbio.2023.100846.


Assessment of the Impacts of (L.) on Cell Viability, and Osteogenic Differentiation of Mesenchymal Stem Cell Spheroids.

Lee H, Na K, Uddin M, Park J Medicina (Kaunas). 2023; 59(1).

PMID: 36676667 PMC: 9863519. DOI: 10.3390/medicina59010043.

References
1.
Rukavina P, Koch F, Wehrle M, Trondle K, Stark G, Koltay P . In vivo evaluation of bioprinted prevascularized bone tissue. Biotechnol Bioeng. 2020; 117(12):3902-3911. DOI: 10.1002/bit.27527. View

2.
Ravi M, Paramesh V, Kaviya S, Anuradha E, Paul Solomon F . 3D cell culture systems: advantages and applications. J Cell Physiol. 2014; 230(1):16-26. DOI: 10.1002/jcp.24683. View

3.
Karageorgiou V, Kaplan D . Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005; 26(27):5474-91. DOI: 10.1016/j.biomaterials.2005.02.002. View

4.
Tung Y, Hsiao A, Allen S, Torisawa Y, Ho M, Takayama S . High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst. 2010; 136(3):473-8. PMC: 7454010. DOI: 10.1039/c0an00609b. View

5.
Laschke M, Schank T, Scheuer C, Kleer S, Shadmanov T, Eglin D . In vitro osteogenic differentiation of adipose-derived mesenchymal stem cell spheroids impairs their in vivo vascularization capacity inside implanted porous polyurethane scaffolds. Acta Biomater. 2014; 10(10):4226-35. DOI: 10.1016/j.actbio.2014.06.035. View